VolitionRx Limited (VNRX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on April 17, 2026, by VolitionRx Limited, a Delaware corporation. The report details a corporate action regarding the company's capital structure, specifically a reverse stock split previously authorized by shareholders at a special meeting on March 31, 2026.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the mechanics of the reverse stock split and related equity adjustments.
Material Changes
The Board of Directors has approved a one-for-twenty (1:20) reverse stock split. This action is being taken in consideration of financing terms with Lind Global Asset Management XII LLC consummated on May 20, 2025, and January 15, 2026. The split is expected to become effective at 12:01 a.m. ET on April 28, 2026. Every 20 shares of common stock will be converted into one share. Fractional shares will not be issued; instead, holders will receive one whole share in lieu of fractional entitlements. Proportionate adjustments will be made to outstanding warrants, options, convertible notes, and shares available under the 2015 and 2024 Stock Incentive Plans.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond the standard implications of a reverse stock split. The primary contingency noted is the rounding up of fractional shares for all equity holders and instruments.
Key Facts for Investor Verification
- Effective Date: The reverse stock split is scheduled to take effect on April 28, 2026.
- Split Ratio: One-for-twenty (1:20).
- Fractional Share Treatment: All fractional shares resulting from the split will be rounded up to the next whole share.
- Related Financing: The split is linked to financing agreements with Lind Global Asset Management XII LLC.
- Trading Impact: Shares are expected to begin trading on a split-adjusted basis at the market open on the effective date.